Variant report

Variant	nsv522039
Chromosome Location	chr6:11769280-11771259
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:224)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:224 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr6:11771145-11771495	A549	lung:	n/a	n/a
2	BACH1	chr6:11770566-11770569	K562	blood:	n/a	n/a
3	BHLHE40	chr6:11770436-11770700	K562	blood:	n/a	n/a
4	BRCA1	chr6:11770592-11771487	Hela-S3	cervix:	n/a	n/a
5	CBX3	chr6:11770836-11771416	K562	blood:	n/a	n/a
6	CEBPB	chr6:11771141-11771532	A549	lung:	n/a	n/a
7	CEBPB	chr6:11771007-11771589	A549	lung:	n/a	n/a
8	CEBPB	chr6:11769343-11769587	K562	blood:	n/a	n/a
9	CEBPB	chr6:11770500-11772203	Hela-S3	cervix:	n/a	n/a
10	CEBPB	chr6:11770940-11772105	IMR90	lung:	n/a	n/a
11	CEBPB	chr6:11770867-11770908	K562	blood:	n/a	n/a
12	CEBPB	chr6:11770970-11771506	A549	lung:	n/a	n/a
13	CEBPB	chr6:11769323-11769512	IMR90	lung:	n/a	n/a
14	CHD2	chr6:11770615-11770651	K562	blood:	n/a	n/a
15	CHD2	chr6:11770402-11772024	Hela-S3	cervix:	n/a	n/a
16	CTCF	chr6:11771100-11771250	AG04449	skin:	n/a	n/a
17	CTCF	chr6:11770460-11770610	NHEK	skin:	n/a	n/a
18	CTCF	chr6:11770540-11770690	HRPEpiC	eye:	n/a	n/a
19	CTCF	chr6:11770560-11770710	HRE	kidney:	n/a	n/a
20	CTCF	chr6:11771080-11771093	NHEK	skin:	n/a	n/a
21	CTCF	chr6:11771180-11771330	HCPEpiC	choroid plexus:	n/a	n/a
22	CTCF	chr6:11771080-11771230	WERI-Rb-1	eye:	n/a	n/a
23	CTCF	chr6:11770560-11770710	HEEpiC	esophagus:	n/a	n/a
24	CTCF	chr6:11771140-11771290	AG04449	skin:	n/a	n/a
25	CTCF	chr6:11771099-11771266	NHEK	skin:	n/a	n/a
26	CTCF	chr6:11770840-11770990	SAEC	small airway:	n/a	n/a
27	E2F4	chr6:11770872-11771501	MCF10A-Er-Src	breast:	n/a	n/a
28	E2F6	chr6:11770893-11771457	A549	lung:	n/a	n/a
29	E2F6	chr6:11770951-11771353	K562	blood:	n/a	n/a
30	E2F6	chr6:11770928-11771455	H1-hESC	embryonic stem cell:	n/a	n/a
31	E2F6	chr6:11770780-11771702	A549	lung:	n/a	n/a
32	E2F6	chr6:11770469-11770658	K562	blood:	n/a	n/a
33	E2F6	chr6:11770872-11771791	H1-hESC	embryonic stem cell:	n/a	n/a
34	EGR1	chr6:11770123-11770333	K562	blood:	n/a	n/a
35	EGR1	chr6:11770797-11771611	HCT-116	colon:	n/a	chr6:11771210-11771223
36	ELF1	chr6:11770936-11771342	GM12878	blood:	n/a	chr6:11771212-11771221
37	ELK1	chr6:11770540-11771420	Hela-S3	cervix:	n/a	n/a
38	EP300	chr6:11771043-11771416	SK-N-SH_RA	brain:	n/a	n/a
39	EP300	chr6:11770759-11771524	Hela-S3	cervix:	n/a	n/a
40	EP300	chr6:11770991-11771568	A549	lung:	n/a	n/a
41	EP300	chr6:11770811-11771762	SK-N-SH	brain:	n/a	n/a
42	FOS	chr6:11769476-11769853	MCF10A-Er-Src	breast:	n/a	n/a
43	FOS	chr6:11770957-11771589	HUVEC	blood vessel:	n/a	n/a
44	FOS	chr6:11770118-11770241	MCF10A-Er-Src	breast:	n/a	n/a
45	FOS	chr6:11769516-11769874	MCF10A-Er-Src	breast:	n/a	n/a
46	FOS	chr6:11769504-11769888	HUVEC	blood vessel:	n/a	n/a
47	FOS	chr6:11769602-11769721	MCF10A-Er-Src	breast:	n/a	n/a
48	FOS	chr6:11770485-11770582	MCF10A-Er-Src	breast:	n/a	n/a
49	FOS	chr6:11769523-11769863	MCF10A-Er-Src	breast:	n/a	n/a
50	FOS	chr6:11770506-11771531	MCF10A-Er-Src	breast:	n/a	n/a

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:11770626..11772377-chr6:11773316..11774913,2	MCF-7	breast:
2	chr6:11755867..11758010-chr6:11770135..11772213,2	K562	blood:
3	chr6:11765488..11768224-chr6:11770343..11774117,3	MCF-7	breast:
4	chr6:11766943..11769804-chr6:12011580..12013984,2	MCF-7	breast:
5	chr6:11766846..11771135-chr6:12008831..12011747,3	K562	blood:
6	chr6:11771227..11772964-chr6:12006863..12009486,2	MCF-7	breast:
7	chr6:11767330..11770016-chr6:11806756..11808382,2	MCF-7	breast:
8	chr6:11760325..11763713-chr6:11770760..11773174,3	MCF-7	breast:
9	chr6:11770371..11771301-chr7:35840308..35841252,2	Hela-S3	cervix:

No data

Variant related genes	Relation type
ADTRP	TF binding region
ENSG00000111863	chromatin interactions
ENSG00000095951	chromatin interactions
ENSG00000229896	chromatin interactions
ENSG00000122545	chromatin interactions

Extended variants
information (count: 96 )
Associated
traits (count: 98 )

Variant overlapped rSNPs/rCNVs (count:96 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9470042	chr6:11769280-11769281	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs78788393	chr6:11769282-11769283	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs564106396	chr6:11769330-11769331	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs55647423	chr6:11769364-11769365	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs16871788	chr6:11769395-11769396	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
6	rs549314434	chr6:11769410-11769411	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs529869942	chr6:11769433-11769434	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs549975519	chr6:11769446-11769447	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs569733921	chr6:11769450-11769451	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs538962992	chr6:11769502-11769503	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs549655181	chr6:11769560-11769561	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs558423400	chr6:11769562-11769563	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs565737319	chr6:11769647-11769648	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs569575660	chr6:11769659-11769660	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs369045814	chr6:11769687-11769688	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs115927055	chr6:11769700-11769701	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs554656300	chr6:11769752-11769753	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs149306352	chr6:11769767-11769768	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs537137427	chr6:11769781-11769782	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs535085118	chr6:11769785-11769786	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs534947578	chr6:11769825-11769826	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs551758339	chr6:11769829-11769830	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs571523658	chr6:11769857-11769858	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs557574553	chr6:11769898-11769899	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs371711036	chr6:11769902-11769903	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs577365116	chr6:11769918-11769919	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs370650765	chr6:11769962-11769963	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs9394301	chr6:11769989-11769990	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs560048784	chr6:11770016-11770017	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs565782123	chr6:11770034-11770035	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs9380513	chr6:11770103-11770104	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs9394302	chr6:11770114-11770115	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs375155730	chr6:11770136-11770137	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs369380870	chr6:11770157-11770158	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs529831292	chr6:11770178-11770179	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs571051259	chr6:11770190-11770191	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs144530104	chr6:11770202-11770203	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs563544985	chr6:11770209-11770210	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs532158096	chr6:11770231-11770232	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs536439611	chr6:11770237-11770238	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs191889833	chr6:11770244-11770245	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs184497023	chr6:11770262-11770263	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs540174240	chr6:11770279-11770280	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs368684774	chr6:11770285-11770286	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs200946315	chr6:11770308-11770309	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs548213264	chr6:11770320-11770321	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs556903967	chr6:11770326-11770327	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs199516715	chr6:11770334-11770335	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs200268228	chr6:11770335-11770336	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs201390984	chr6:11770358-11770359	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:98)

Disease	PMID	Source
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
small cell lung cancer	20016488	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Osteosarcoma	16790693	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Ovarian cancer	21720365	CNVD
Cancer	21183584	CNVD
Acute myeloid leukemia	18000384	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21364760	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Bladder cancer	21909424	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Burkitt''s lymphoma	19759907	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Metastatic melanoma	18483359	CNVD

Chromatin state (count:206 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:11759400-11769600	Weak transcription	Lung	lung
2	chr6:11760600-11770600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
3	chr6:11762600-11770600	Weak transcription	Spleen	Spleen
4	chr6:11763200-11773400	Enhancers	HUVEC	blood vessel
5	chr6:11764400-11770600	Weak transcription	Esophagus	oesophagus
6	chr6:11764400-11770600	Weak transcription	Left Ventricle	heart
7	chr6:11764400-11770600	Weak transcription	Right Atrium	heart
8	chr6:11764800-11769600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
9	chr6:11764800-11769600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
10	chr6:11765000-11770600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
11	chr6:11765800-11770200	Enhancers	Hela-S3	cervix
12	chr6:11765800-11770600	Enhancers	HSMM	muscle
13	chr6:11765800-11770600	Enhancers	Osteobl	bone
14	chr6:11765800-11773000	Enhancers	NH-A	brain
15	chr6:11765800-11773600	Enhancers	NHDF-Ad	bronchial
16	chr6:11765800-11773600	Enhancers	NHLF	lung
17	chr6:11766000-11770800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
18	chr6:11766200-11770800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
19	chr6:11766400-11769800	Enhancers	Gastric	stomach
20	chr6:11766600-11770800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
21	chr6:11766800-11770600	Enhancers	Muscle Satellite Cultured Cells	--
22	chr6:11766800-11771800	Enhancers	Fetal Intestine Small	intestine
23	chr6:11766800-11773000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
24	chr6:11767000-11771800	Enhancers	Stomach Mucosa	stomach
25	chr6:11767200-11769400	Weak transcription	Placenta	Placenta
26	chr6:11767200-11769600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
27	chr6:11767200-11770600	Weak transcription	Rectal Smooth Muscle	rectum
28	chr6:11767200-11770800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
29	chr6:11767400-11769400	Weak transcription	Duodenum Smooth Muscle	Duodenum
30	chr6:11767400-11770400	Weak transcription	Adipose Nuclei	Adipose
31	chr6:11767400-11770600	Weak transcription	Fetal Lung	lung
32	chr6:11767600-11769400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
33	chr6:11767600-11770400	Weak transcription	Pancreas	Pancrea
34	chr6:11767600-11771000	Enhancers	HSMMtube	muscle
35	chr6:11767600-11771200	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
36	chr6:11767800-11770200	Weak transcription	HUES6 Cell Line	embryonic stem cell
37	chr6:11767800-11770400	Enhancers	Duodenum Mucosa	Duodenum
38	chr6:11767800-11770800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
39	chr6:11768000-11769600	Weak transcription	A549	lung
40	chr6:11768000-11769800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
41	chr6:11768000-11770000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
42	chr6:11768000-11770000	Weak transcription	HUES48 Cell Line	embryonic stem cell
43	chr6:11768000-11770200	Weak transcription	Colon Smooth Muscle	Colon
44	chr6:11768000-11770400	Weak transcription	H9 Cell Line	embryonic stem cell
45	chr6:11768000-11770400	Weak transcription	Stomach Smooth Muscle	stomach
46	chr6:11768000-11770600	Weak transcription	H1 Cell Line	embryonic stem cell
47	chr6:11768200-11769400	Genic enhancers	HMEC	breast
48	chr6:11768200-11770200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
49	chr6:11768400-11769400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
50	chr6:11768400-11769400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links